The Pfizer Clinical Research Unit (PCRU) in Brussels is seeking healthy participants for a clinical trial of a study drug for the treatment of long-term weight management and other weight-related health conditions.

The purpose is to investigate an experimental medicine that works on appetite-control.

Who may participate

This study is seeking healthy male and female participants. Participants must be healthy, meaning they will not have the condition for which this treatment is being developed and are in overall good health. You may not take part in this study if:

  • You are younger than 18 years or you weigh less than or equal to 50 kg or you are outside of the limits for Body Mass Index (27 - 45 kg/m2 or 22 - 45 kg/m2 for Japanese participants). 
  • For the Japanese Cohort: You do not have 4 biological Japanese grandparents who were born in Japan. 
  • You have a medical condition that significantly affects how your stomach empties food.
     

There are other requirements for participation in this study. 

Please read attentively the Informed Consent Document (ICD), more explanation will be provided by the study staff during the screening process. 

 

Condition

Healthy

Age

18+

Sex

Male and female

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in Brussels, Belgium. 

The study will last for about 12 weeks. You will stay in the PCRU for 1 treatment period, comprised of 9 days and 8 nights. You will have 5 check-up visits. 

You will be screened within 28 days prior to the first dose of study intervention.

Throughout the study, staff will closely monitor your health status and collect data.

You will not personally derive any benefit from your participation in this study, but the results obtained could be very important for the development of medicines and treatments which will benefit other people.
 

View calendar

How long is the study?

Approximately 12 weeks

Compensation

Up to € 3.560, plus travel fees

Interested in participating?

Whether you are new to clinical research or already in our database, if you’d like to subscribe for this study, please use the PCRU Chatbot Charlie at the bottom right of the screen.